Agilon Health announced a significant leadership change, with Steven Sell stepping down as President, CEO, and Board Director, effective August 4, 2025. Ronald A. Williams, co-founder and Board Chairman, has been appointed Executive Chairman, and the Board has initiated a search for a permanent CEO.
In conjunction with the leadership transition, the company withdrew its full-year 2025 financial guidance, citing market uncertainty and the need for additional optimization actions. This decision reflects a strategic recalibration under the new leadership.
For the second quarter ended June 30, 2025, Agilon Health reported total revenues of $1.39 billion, a 6% decrease year-over-year, and a negative medical margin of $53 million, a sharp decline from $106 million in Q2 2024. The net loss for the quarter was $104 million, compared to a net loss of $31 million in the prior year period, driven by lower-than-expected risk adjustment and unfavorable Part D costs.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.